These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12370751)

  • 1. Ribozyme mediated cleavage of cell-associated isoform of vascular endothelial growth factor inhibits liver metastasis of a pancreatic cancer cell line.
    Tokunaga T; Abe Y; Tsuchida T; Hatanaka H; Oshika Y; Tomisawa M; Yoshimura M; Ohnishi Y; Kijima H; Yamazaki H; Ueyama Y; Nakamura M
    Int J Oncol; 2002 Nov; 21(5):1027-32. PubMed ID: 12370751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental study of anti-vascular endothelial growth factor hairpin ribozyme gene inhibiting growth of xenografted tumor of ovarian cancer cells].
    Yan R; Xin X; Jin M; Hui H; Wang J; Wang D
    Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):683-6. PubMed ID: 12487926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique properties of 189 amino acid isoform of vascular endothelial growth factor in tumorigenesis.
    Tomii Y; Yamazaki H; Sawa N; Ohnishi Y; Kamochi J; Tokunaga T; Osamura Y; Sadahiro S; Kijima H; Abe Y; Ueyama Y; Tamaoki N; Nakamura M
    Int J Oncol; 2002 Dec; 21(6):1251-7. PubMed ID: 12429975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental study of anti-VEGF hairpin ribozyme gene inhibiting expression of VEGF and proliferation of ovarian cancer cells].
    Yan RL; Qian XH; Xin XY; Jin M; Hui HX; Wang DT; Wang J
    Ai Zheng; 2002 Jan; 21(1):39-44. PubMed ID: 12500395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors.
    Pavco PA; Bouhana KS; Gallegos AM; Agrawal A; Blanchard KS; Grimm SL; Jensen KL; Andrews LE; Wincott FE; Pitot PA; Tressler RJ; Cushman C; Reynolds MA; Parry TJ
    Clin Cancer Res; 2000 May; 6(5):2094-103. PubMed ID: 10815937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
    Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
    Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vascular endothelial growth factor gene expression in nasopharyngeal carcinoma cell line induced by hypoxia in vitro].
    Yang HF; Tang WP
    Ai Zheng; 2003 Feb; 22(2):160-3. PubMed ID: 12600291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line.
    Tokunaga T; Tsuchida T; Kijima H; Okamoto K; Oshika Y; Sawa N; Ohnishi Y; Yamazaki H; Miura S; Ueyama Y; Nakamura M
    Br J Cancer; 2000 Sep; 83(6):833-9. PubMed ID: 10952790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma.
    Dagnaes-Hansen F; Rasmussen LM; Tilton R; Denner L; Flyvbjerg A
    Anticancer Res; 2003; 23(2B):1625-30. PubMed ID: 12820432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
    Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
    Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.
    Sipos B; Weber D; Ungefroren H; Kalthoff H; Zühlsdorff A; Luther C; Török V; Klöppel G
    Int J Cancer; 2002 Dec; 102(6):592-600. PubMed ID: 12448000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor isoform expression as a determinant of blood vessel patterning in human melanoma xenografts.
    Yu JL; Rak JW; Klement G; Kerbel RS
    Cancer Res; 2002 Mar; 62(6):1838-46. PubMed ID: 11912163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction.
    Masui T; Hosotani R; Doi R; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Tulachan SS; Imamura M
    Anticancer Res; 2002; 22(6C):4093-100. PubMed ID: 12553038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process.
    Barbera-Guillem E; Nyhus JK; Wolford CC; Friece CR; Sampsel JW
    Cancer Res; 2002 Dec; 62(23):7042-9. PubMed ID: 12460925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
    McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W
    J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
    Zielke A; Middeke M; Hoffmann S; Colombo-Benkmann M; Barth P; Hassan I; Wunderlich A; Hofbauer LC; Duh QY
    Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
    Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.